Transcription factor EB (TFEB) is a new therapeutic target for Pompe disease
Carmine Spampanato(University of Campania "Luigi Vanvitelli"), Nina Raben(APT Therapeutics (United States))
Cited by 337
Related Papers
Activation of the endoplasmic reticulum stress response in autoimmune myositis: Potential role in muscle fiber damage and dysfunction
|Arthritis & Rheumatism|2005|345
Conditional up-regulation of MHC class I in skeletal muscle leads to self-sustaining autoimmune myositis and myositis-specific autoantibodies
|Proceedings of the National Academy of Sciences|2000|314
Dysfunction of endocytic and autophagic pathways in a lysosomal storage disease
|Annals of Neurology|2006|300
Targeted Disruption of the Acid α-Glucosidase Gene in Mice Causes an Illness with Critical Features of Both Infantile and Adult Human Glycogen Storage Disease Type II
|Journal of Biological Chemistry|1998|298
Histidyl–tRNA Synthetase and Asparaginyl–tRNA Synthetase, Autoantigens in Myositis, Activate Chemokine Receptors on T Lymphocytes and Immature Dendritic Cells
|The Journal of Experimental Medicine|2002|276